Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure.
Noll L CampbellChristopher PittsClaire CorvariEllen KaehrKhalid AlamerParveen ChandKristine NanagasChristopher M CallahanMalaz A BoustaniPublished in: Journal of the American College of Clinical Pharmacy : JACCP (2022)
Pharmacist-based deprescribing successfully reduced exposure to high-risk anticholinergics in primary care older adults, yet further work is needed to understand the impact on clinical outcomes.